Evidence map›Paper›PMID 32059385›Full record

ArticleMedicina (Kaunas, Lithuania)2020

Bmi-1 Immunohistochemical Expression in Endometrial Carcinoma is Correlated with Prognostic Activity.

Kayo Horie, Chihiro Iseki, Moe Kikuchi, Keita Miyakawa, Mao Yoshizaki, Haruhiko Yoshioka, Jun Watanabe

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kayo HorieDepartment of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Chihiro IsekiDepartment of Medical Technology, Hirosaki University School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Moe KikuchiDepartment of Medical Technology, Hirosaki University School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Keita MiyakawaDepartment of Medical Technology, Hirosaki University School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Mao YoshizakiDepartment of Medical Technology, Hirosaki University School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Haruhiko YoshiokaDepartment of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Jun WatanabeDepartment of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
Hirosaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Predictive Value of TestsAgedBiomarkers, TumorBiopsyCyclin AEarly Detection of CancerEndometrial NeoplasmsFemaleHumansImmunohistochemistryJapanKi-67 AntigenMiddle AgedPolycomb Repressive Complex 1Tumor Suppressor Protein p53Biomarkers, TumorBMI1 protein, humanCyclin AKi-67 AntigenMKI67 protein, humanPolycomb Repressive Complex 1Tumor Suppressor Protein p53biomarkerBmi-1endometrial carcinomaimmunohistochemical staining

Identifiers

PMID32059385
PMCPMC7074093
OpenAlexW3005642013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.